Growth Metrics

Eli Lilly (LLY) Tax Rate Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 435.00
Dec 31, 2025 1,213.00
Sep 30, 2025 1,554.00
Jun 30, 2025 378.00
Mar 31, 2025 1,283.00
Dec 31, 2024 629.00
Sep 30, 2024 2,806.00
Jun 30, 2024 286.00
Mar 31, 2024 336.00
Dec 31, 2023 -155.00
Sep 30, 2023 9,752.00
Jun 30, 2023 150.00
Mar 31, 2023 -122.00
Dec 31, 2022 -250.00
Sep 30, 2022 -354.00
Jun 30, 2022 323.00
Mar 31, 2022 -1,591.00
Dec 31, 2021 2,656.00
Sep 30, 2021 -760.00
Jun 30, 2021 -64,262.00
Mar 31, 2021 -633.00
Dec 31, 2020 -48,152.00
Sep 30, 2020 983.00
Jun 30, 2020 -594.00
Mar 31, 2020 -26,775.00
Dec 31, 2019 -341.00
Sep 30, 2019 -905.00
Jun 30, 2019 -1,137.00
Mar 31, 2019 90.00
Dec 31, 2018 -1,277.00
Sep 30, 2018 -522.00
Jun 30, 2018 64,379.00
Mar 31, 2018 23.00
Dec 31, 2017 47,922.00
Sep 30, 2017 -1,755.00
Jun 30, 2017 -197.00
Mar 31, 2017 26,276.00
Dec 31, 2016 -657.00
Sep 30, 2016 -65.00
Jun 30, 2016 46.00
Mar 31, 2016 169.00
Dec 31, 2015 -2,590.00
Sep 30, 2015 -556.00
Jun 30, 2015 -1,050.00
Mar 31, 2015 -997.00
Dec 31, 2014 -105.00
Sep 30, 2014 591.00
Jun 30, 2014 19.00
Mar 31, 2014 117.00
Dec 31, 2013 302.00
Sep 30, 2013 -154.00
Jun 30, 2013 -194.00
Mar 31, 2013 -626.00
Dec 31, 2012 -121.00
Sep 30, 2012 1,730.00
Jun 30, 2012 104.00
Mar 31, 2012 228.00